Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival-Reference-Cited by-同舟云学术

Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival

Published:2007-01 Issue:1 Volume:203 Page:274-278
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Cho Seongeun,Hu Yun

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference26 articles.

1. Globular amyloid beta-peptide oligomer—A homogenous and stable neuropathological protein in Alzheimer's disease;Barghorn;J. Neurochem.,2005

2. Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives;Bockaert;Mol. Pharmacol.,1990

3. {beta}-Amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's, disease;Buttini;J. Neurosci.,2005

4. Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease;Comery;J. Neurosci.,2005

5. 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex;Consolo;NeuroReport,1994

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dorsal raphe nucleus–hippocampus serotonergic circuit underlies the depressive and cognitive impairments in 5×FAD male mice;Translational Neurodegeneration;2024-07-24

2. Studies on the mechanisms of action of MR33317;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-10

3. The Serotonin 4 Receptor Subtype: A Target of Particular Interest, Especially for Brain Disorders;International Journal of Molecular Sciences;2024-05-11

4. Putative pathological mechanisms of late-life depression and Alzheimer’s disease;Brain Research;2023-08

5. Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment;NeuroImage: Clinical;2023